Stockscreener 앱 받기
2.09
13.28%
-0.32
시간 외 거래:
2.09
전일 마감가:
$2.41
열려 있는:
$2.43
하루 거래량:
476.11K
Relative Volume:
3.21
시가총액:
$109.39M
수익:
$96.63M
순이익/손실:
$-63.32M
주가수익비율:
-1.0609
EPS:
-1.97
순현금흐름:
$-54.55M
1주 성능:
-35.09%
1개월 성능:
-33.44%
6개월 성능:
-26.67%
1년 성능:
-51.73%
1일 변동 폭
$1.9901
$2.43
1주일 범위
$1.9901
$3.26
52주 변동 폭
$1.88
$6.31
아코야 바이오 Stock (AKYA) Company Profile
명칭
Akoya Biosciences Inc
전화
855.896.8401
주소
100 CAMPUS DRIVE, MARLBOROUGH
AKYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| AKYA | 2.09 | 109.39M | 96.63M | -63.32M | -54.55M | -1.97 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
아코야 바이오 Stock (AKYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-02-02 | 개시 | UBS | Buy |
| 2022-11-03 | 개시 | CapitalOne | Overweight |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-06-22 | 개시 | BTIG Research | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-05-11 | 개시 | Canaccord Genuity | Buy |
| 2021-05-11 | 개시 | JP Morgan | Overweight |
| 2021-05-11 | 개시 | Morgan Stanley | Overweight |
| 2021-05-11 | 개시 | Piper Sandler | Overweight |
모두보기
아코야 바이오 주식(AKYA)의 최신 뉴스
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook - Yahoo Finance
Canaccord Genuity Group Issues Pessimistic Forecast for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Akoya Biosciences shares target cut, maintains buy rating on Q3 results - Investing.com
Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold - MSN
Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold (NASDAQ:AKYA) - Seeking Alpha
Canaccord Genuity Group Has Lowered Expectations for Akoya Biosciences (NASDAQ:AKYA) Stock Price - MarketBeat
Akoya Biosciences (NASDAQ:AKYA) Stock Rating Lowered by Craig Hallum - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2024 Earnings Call Transcript - Insider Monkey
Akoya Biosciences Shares Sink After FY24 Outlook Cut - MarketWatch
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 20.8% in October - MarketBeat
Akoya Biosciences, Inc. Revises Earnings Guidance for the Full Year 2024 - Marketscreener.com
Akoya: Q3 Earnings Snapshot - Darien Times
Akoya Biosciences Reports Q3 2024 Financial Results - TipRanks
Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Akoya Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Akoya Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt? - Simply Wall St
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Akoya Biosciences (AKYA) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences - PR Newswire
Akoya Biosciences Unveils a New Era in Spatial Content - GlobeNewswire
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel - Yahoo Finance
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Decrease in Short Interest - MarketBeat
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 - StockTitan
BTIG Downgrades Akoya Biosciences (AKYA) - MSN
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives $6.56 Consensus Price Target from Brokerages - MarketBeat
Akoya Biosciences (AKYA) Stock Price, News & Analysis - MarketBeat
Akoya Biosciences Inc (AKYA) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock Rockets 36% But Many Are Still Ignoring The Company - Simply Wall St
Akoya Biosciences joins UK cancer research initiative By Investing.com - Investing.com South Africa
Akoya Biosciences joins UK cancer research initiative - Investing.com India
Akoya’s Leading Spatial Proteomics Platforms Selected for - GlobeNewswire
Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy - The Manila Times
Akoya's Leading Spatial Proteomics Platforms Selected for Use by Uk-Based Manifest Consortium to Revolutionize Cancer Immunotherapy - Marketscreener.com
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy - StockTitan
IPO Alert: Akoya Biosciences - RTTNews
Akoya Biosciences appoints new chairman By Investing.com - Investing.com South Africa
Akoya Biosciences Appoints Scott Mendel as Chairman of the Board of Directors - citybiz
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors - ForexTV.com
Akoya Biosciences appoints new chairman - Investing.com
Akoya Biosciences names Scott Mendel as new board chairman By Investing.com - Investing.com Australia
Akoya Biosciences names Scott Mendel as new board chairman - Investing.com
Spatial Proteomics Market Size, Share, Growth Report, 2030 - Grand View Research
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Decline in Short Interest - MarketBeat
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth By Investing.com - Investing.com South Africa
Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth - Investing.com
Caxton Associates LP Takes $2.23 Million Position in American International Group, Inc. (NYSE:AIG) - Defense World
Global Spatial Omics Market Projected to Reach $ 424.2 Million by 2032, Growing at 10.5% CAGR - 대구포스트
아코야 바이오 (AKYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.70%
3.32%
자본화:
|
볼륨(24시간):